Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes.
about
A systems biology approach to identify effective cocktail drugs.Vav3, a GEF for RhoA, Plays a Critical Role under High Glucose Conditions.A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes.Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes.Peroxisome proliferator-activated receptor activating hypoglycemic effect of Gardenia jasminoides Ellis aqueous extract and improvement of insulin sensitivity in steroid induced insulin resistant rats.Patient adherence to medication requirements for therapy of type 2 diabetes.Metformin, an old drug, brings a new era to cancer therapyMetformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells.Grape seed proanthocyanidins and metformin act by different mechanisms to promote insulin signaling in rats fed high calorie diet.Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus.Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin.Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well-controlled Type 2 diabetes.
P2860
Q33692329-60D951FC-AE8D-4485-91D1-40D39170A1DAQ34318871-0BD53E20-AD6D-4D1D-A68F-D387602848BFQ35987436-04EFAE40-2DF0-4FF3-B93B-A5E7B5EC235EQ36847318-91D2136C-D39C-4965-8C0C-CFFB9C318142Q37501666-6DE94E87-4623-49AC-98C7-BF0960B7D847Q37840269-217C5967-091E-4E7D-AF9A-A64C63B1FDEEQ38393435-69EB298D-13AF-4698-AAF5-665BCB46C8E4Q38475375-999DDFA4-D1B8-4C8D-973B-C78B2EA197ECQ38586385-DF84081D-3FAF-4E7E-AC5A-FC69292FD184Q47333601-2F717FB2-530A-40FA-9140-6B75A94C39F4Q51480621-4DAD6E59-B05A-4EF4-A07C-84B5CCC7CFBAQ51489759-E3583473-A018-4180-A30B-42671B0967AE
P2860
Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Avandamet: combined metformin- ...... resistance in type 2 diabetes.
@ast
Avandamet: combined metformin- ...... resistance in type 2 diabetes.
@en
type
label
Avandamet: combined metformin- ...... resistance in type 2 diabetes.
@ast
Avandamet: combined metformin- ...... resistance in type 2 diabetes.
@en
prefLabel
Avandamet: combined metformin- ...... resistance in type 2 diabetes.
@ast
Avandamet: combined metformin- ...... resistance in type 2 diabetes.
@en
P2860
P1476
Avandamet: combined metformin- ...... resistance in type 2 diabetes
@en
P2093
P2860
P304
P356
10.1111/J.1742-1241.2004.00318.X
P577
2004-09-01T00:00:00Z